Shenzhen Neptunus Bioengineering plans to raise CNY1bn ($150.69m) through the private placement of debt financing instruments.

The Chinese biochemical pharmaceuticals company plans to use the funds towards gold operations and repayment of debt.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Indian pharmaceutical company Denis Chem Lab plans to issue 21 million shares of its common stock priced at Rs84 ($1.31) a share to raise Rs179.32m ($2.8m).

Chinese healthcare solutions provider Humanwell Healthcare (Group) plans to dispose its bio-pharma unit for CNY350m ($53.01m).

Pharmaceutical Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Awarded the 2025 Pharmaceutical Technology Excellence Award for Business Expansion in Integrated Manufacturing, Upperton Pharma Solutions is rapidly expanding its UK GMP and sterile manufacturing footprint. Find out how Upperton’s integrated CDMO model helps pharma companies move from early development to clinical and niche commercial supply with fewer handovers and faster timelines.

Discover the Impact